Spacelabs Releases New Ambulatory Blood Pressure Module

ISSAQUAH, Wash.--(BUSINESS WIRE)--Spacelabs Healthcare has released the latest version of their Cardiology Information Management System –Sentinel v.9 –with a new seamlessly integrated ABP module.

“We are out in the field regularly talking to doctors and nurses about their concerns”

The module provides new innovations using SMS messaging for treatment compliance, serial comparisons of results and reports, and remote programming and downloading of recorders via the Web, making Sentinel v.9 a world class software solution for the diagnosis and treatment of hypertension.

“We are out in the field regularly talking to doctors and nurses about their concerns,” said Nicholas Ong, Spacelabs President. “This ABP module was inspired by healthcare providers looking for a better solution to hypertension management.”

The integration of the ABP module into the Sentinel platform provides the flexibility to deploy a software solution from a small clinic, to a hospital, to a Web-based multi centered clinical study system. Results can be easily integrated into Electronic Medical Records (EMR) along with other cardiology reports.

Discover all of the benefits of Spacelabs’ Cardiology Information Management System, Sentinel, at http://www.spacelabshealthcare.com/en/product/sentinel/.

About Spacelabs Healthcare, Inc.

Spacelabs Healthcare, Inc.(www.spacelabshealthcare.com), a wholly-owned subsidiary of OSI Systems, Inc., is an international developer, manufacturer and distributor of medical equipment and services including solutions for patient monitoring and connectivity, anesthesia delivery and ventilation, diagnostic cardiology and supplies and accessories selling to hospitals, clinics and physician offices. The Company has offices in the United States, United Kingdom, Canada, France, Germany, Italy, China, India and Singapore and distribution partners in more than 100 countries around the world.

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such statements include information regarding the Company’s expectations, goals or intentions about the future, including, but not limited to, statements regarding the performance of the Company’s products. The actual results may differ materially from those described in or implied by any forward-looking statement. Other important factors are set forth in the Securities and Exchange Commission filings of OSI Systems, Inc. All forward-looking statements speak only as of the date made, and we undertake no obligation to update these forward-looking statements.